Robyn Lynn Leary

Title: Robyn Lynn Leary: Innovator in Diagnostic Methods

Introduction

Robyn Lynn Leary is a notable inventor based in La Jolla, California. She has made significant contributions to the field of diagnostics through her innovative work involving endogenous retrovirus proteins. Her research focuses on the potential of these proteins as diagnostic markers and therapeutic agents.

Latest Patents

Robyn Lynn Leary holds 1 patent for her invention titled "Compositions and methods involving endogenous retrovirus proteins." This patent describes methods and compositions that utilize endogenous retrovirus proteins as diagnostic markers. The detection of these proteins on a cell surface can indicate early neoplasticity of the cell. Furthermore, antibody compositions that specifically bind to cell-surface-expressed endogenous retrovirus proteins can be employed in diagnostic methods. The overexpression of these proteins has been shown to slow cell growth and decrease cell viability.

Career Highlights

Leary is affiliated with the Regents of the University of Minnesota, where she continues her research and development in the field of diagnostics. Her work has the potential to impact the early detection of neoplastic conditions, thereby improving patient outcomes.

Collaborations

Robyn Lynn Leary has collaborated with notable colleagues such as Anindya Bagchi and Aaron Lyman Sarver. These collaborations have further enriched her research and contributed to the advancement of diagnostic methods.

Conclusion

Robyn Lynn Leary's innovative work in the field of diagnostics highlights the importance of endogenous retrovirus proteins in medical applications. Her contributions are paving the way for new diagnostic techniques that could significantly enhance early detection and treatment options.